Patents by Inventor Nicholas D. Mullins

Nicholas D. Mullins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MANUFACTURING A PRODUCT USING CAUSAL MODELS
    Publication number: 20250036112
    Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for optimizing a process of manufacturing a product. In one aspect, the method comprises repeatedly performing the following: i) selecting a configuration of input settings for manufacturing a product, based on a causal model that measures causal relationships between input settings and a measure of a quality of the product; ii) determining the measure of the quality of the product manufactured using the configuration of input settings; and iii) adjusting, based on the measure of the quality of the product manufactured using the configuration of input settings, the causal model.
    Type: Application
    Filed: October 16, 2024
    Publication date: January 30, 2025
    Inventors: Brian E. Brooks, Gilles J. Benoit, Peter O. Olson, Tyler W. Olson, Himanshu Nayar, Frederick J. Arsenault, Nicholas A. Johnson, Brett R. Hemes, Thomas J. Strey, Jonathan B. Arthur, Nathan J. Herbst, Aaron K. Nienaber, Sarah M. Mullins, Mark W. Orlando, Cory D. Sauer, Timothy J. Clemens, Scott L. Barnett, Zachary M. Schaeffer, Patrick G. Zimmerman, Gregory P. Moriarty, Jeffrey P. Adolf, Steven P. Floeder, Andreas Backes, Peter J. Schneider, Maureen A. Kavanagh, Glenn E. Casner, Miaoding Dai, Christopher M. Brown, Lori A. Sjolund, Jon A. Kirschhoffer, Carter C. Hughes
  • Phosphonucleosides useful in the treatment of viral disorders
    Patent number: 9822137
    Abstract: A first aspect of the invention relates to a compound of formula (I), or a pharmaceutically acceptable salt or prodrug thereof, wherein the groups are as defined in the claims. Further aspects of the invention relate to pharmaceutical compositions comprising compounds of formula (I), and the use of compounds of formula (I) in the preparation of a medicament for treating a viral disorder.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: November 21, 2017
    Assignees: UNIVERSITY COLLEGE CORK, KATHOLIEKE UNIVERSITEIT LEUVEN
    Inventors: Wim Dehaen, Jan Balzarini, Anita Maguire, Sarah Jane Keane, Alan Ford, Nuala Maguire, Nicholas D. Mullins
  • PHOSPHONUCLEOSIDES USEFUL IN THE TREATMENT OF VIRAL DISORDERS
    Publication number: 20150291640
    Abstract: A first aspect of the invention relates to a compound of formula (I), or a pharmaceutically acceptable salt or prodrug thereof, wherein the groups are as defined in the claims. Further aspects of the invention relate to pharmaceutical compositions comprising compounds of formula (I), and the use of compounds of formula (I) in the preparation of a medicament for treating a viral disorder.
    Type: Application
    Filed: November 20, 2013
    Publication date: October 15, 2015
    Inventors: Wim Dehaen, Jan Balzarini, Anita Maguire, Sarah Jane Keane, Alan Ford, Nuala Maguire, Nicholas D. Mullins